Prepared by the Antarctic Wildlife Health Network (AWHN) and Joint Expert Group for Human Biology and Medicine (JEGHBM)
First published 3rd December 2024; updated 18 December 2024
Since 2021, the global wildlife pandemic caused by Highly Pathogenic Avian Influenza (HPAI) H5N1 clade 2.3.4.4b (hereafter, HPAI) has impacted over 350 species of wild birds and 60 species of mammals (Klaassen and Wille 2023; FAO 2024). As well as the diversity of wildlife affected, HPAI is having population and species level consequences. For example, ~40% of Peruvian Pelicans in Peru, (Wille and Waldenstrom 2023; Leguia et al 2023) and 9% of all South American Sea lions (Plaza et al 2024) in South America died. While the global impacts of HPAI are unknown, (Klaassen and Wille 2023) it is expected that millions of wild birds have died due to this virus since 2021. Based on advice from experts, in 2022, SCAR and IAATO submitted Heightened risk of avian influenza in the Southern Ocean to SC-CAMLR-41 (SC-CAMLR41/BG/20). In 2022, the SCAR Antarctic Wildlife Health Network (AWHN) prepared a biological risk assessment, recommendations and guidelines for researchers, and the Antarctic tourism industry in preparation for the arrival of HPAI into the region. COMNAP used that biological risk assessment to develop and share COMNAP HPAI preparedness and response guidance for National Antarctic Programs. HPAI arrived in the Antarctic region through natural migration of wildlife during the austral summer in 2023/24.
The Updated Biological Risk Assessment and Recommendations for Highly Pathogenic Avian Influenza in Antarctica provides an update to the SCAR AWHN biological risk assessment and previous recommendations.